Skip to content

Discontinued — last reported Q4 '25

EBIT at other companies

Sionna Therapeutics, Inc. Common Stock logo
Sionna Therapeutics, Inc. Common StockSION
-$29.6M-50.6%
Pfizer logo
PfizerPFE
Philip Morris International logo
Philip Morris InternationalPM

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Calculated from Achieve Life Sciences’s reported figures.

The official record: Achieve Life Sciences’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's EBIT?
Achieve Life Sciences (ACHV) reported EBIT of -$13.41M in Q4 2025.
How has Achieve Life Sciences's EBIT changed year-over-year?
Achieve Life Sciences's EBIT decreased by 37.4% year-over-year, from -$9.76M to -$13.41M.
What is the long-term trend for Achieve Life Sciences's EBIT?
Over 4 years (2021 to 2025), Achieve Life Sciences's EBIT has grown at a 12.9% compound annual growth rate (CAGR), from -$33.15M to -$53.83M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.